Associated Papers
Prevalence and clinical significance of mediator complex subunit 12 mutations in 362 Han Chinese samples with uterine leiomyoma.
Wu J et al.
Oncology Letters, 2017
Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas.
Heinonen HR et al.
Scientific Reports, 2017
28432313 (PubMed )
Supplement: 41598_2017_1199_MOESM1_ESM.pdf
MED12 is frequently mutated in breast phyllodes tumours: a study of 112 cases.
Ng CC et al.
Journal of Clinical Pathology, 2015
Frequent MED12 mutations in phyllodes tumours of the breast.
Yoshida M et al.
British Journal of Cancer, 2015
Molecular topography of the MED12-deleted region in smooth muscle tumors: a possible link between non-B DNA structures and hypermutability.
Markowski DN et al.
Molecular Cytogenetics, 2013
MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas.
Mäkinen N et al.
Science (new York, N.y.), 2011
Select a paper to view details